Reprints of Past Articles
Choose by: Topic | Title | Date of Publication

Welcome to the ARCHIVE of Pharma Marketing News reprints. The majority of the following reprints are available at NO CHARGE. If there is a charge, you can order and pay online by credit card for IMMEDIATE delivery of PDF files to you by e-mail. No subscription is required to order reprints. John Mack, Publisher & Editor editor@news.pharma-mkting.com

2011 Reprint List

Choose a different year: 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 December 21, 2011 (Vol. 10, Issue #19) Executive Summary of Complete Issue Proposed Rules for Physician Payment Sunshine Act Certain Physician-Drug Industry Relationships Have Declined Dramatically Politics Vs. Science in the Plan B Decision Checking Under the Hood of Pharma Mobile Apps December 1, 2011 (Vol. 10, Issue #18) Executive Summary of Complete Issue The Digital Life of Doctors The Changing Pharma eDetailing Landscape Limiting Bias in Commercially Supported CME Pfizer Battles to Protect Lipitor Cash Cow Deconstructing Pitts' Guiding Principles for Pharma Social Media Are Pharma Sales Reps Service Employees? November 10, 2011 (Vol. 10, Issue #17) Executive Summary of Complete Issue Stakeholder Effectiveness Johnson & Johnson's ennTV Pfizer's Chapstick Slapstick Facebook Fiasco Pharma YouTube Patient Videos Lack Transparency Pharma Turns Up Heat to Unchill Off-Label "Free Speech" Are Pharma Reps Important to Docs or Not? October 27, 2011 (Vol. 10, Issue #16) Executive Summary of Complete Issue Everything You Need to Know About Mobile Platforms How to Score With Women (as a Marketer) via Social Media Double Dip in DTC Ad Spend! Is There an Upward Career Path for Pharma Social Media Pioneers? Without Free Gifts from Pharma to Docs, Would Research be Useless? Antidepressants: Top Advertised & 3rd Most Commonly Used Rx Drug October 12, 2011 (Vol. 10, Issue #15) Executive Summary of Complete Issue Physician Participation in Peer-to-Peer Social Media Sites The Pozen Digital Advisory Board In Memory of Steve Jobs Will Novartis Sales Reps Really Embrace iPads? The Big C in the Big Apple PhRMA Masters the Art of "Proofiness!" September 22, 2011 (Vol. 10, Issue #14) Executive Summary of Complete Issue Boehringer vs Facebook Social Media Socialism New Big Pharma Economies of Scale Orphan Drugs Now "Where the Money Is," Says Willie Sutton's Ghost Pharma's Physician Bailout August 23, 2011 (Vol. 10, Issue #13) Executive Summary of Complete Issue British Pharma Digital Update Four Useful Lessons Pharma Can Learn from the Pfizer Facebook Hack PR & Interactive Agencies Vie for Pharma Social Media Campaign Crumbs Pharma Facebook Pages Being Phased Out: A Good Run While It Lasted! Vast Majority of Drug Ads in Leading Medical Journals Don't Pass MDs' Sniff Test! July 20, 2011 (Vol. 10, Issue #12) Executive Summary of Complete Issue Adobe Connect for eDetailing The Digital Health Coalition Citizen Petition Likely to Delay FDA Social Media Guidance Tracking Public Health Trends: Twitter vs Google vs Your Nose Pfizer, Show Us Your Social Media "Playbook" June 21, 2011 (Vol. 10, Issue #11) Executive Summary of Complete Issue Finding the Consumer Within the Patient Fair Social Media Practice Principles Most Credible Bad Ad Complaints are Submitted by Pharma The British Pharmaceutical Industry Issues Social Media Guidance for Adverse Event Reporting The Twelve Steps of Pharma Social Marketers Anonymous June 8, 2011 (Vol. 10, Issue #10) Executive Summary of Complete Issue The Pharmaguy Social Media Timeline™ A Pharma Social Media Conspiracy Theory: FDA, DOJ vs. Google FDA Drops Social Media from Its Guidance Agenda May 18, 2011 (Vol. 10, Issue #9) Executive Summary of Complete Issue Pharma SmartPhone/Tablet Apps: Is There a Regulation for That? Challenges of Regulating Mobile Medical Apps Consequences of eDetailing Technology Physicians Are Concerned That Pharma Supported CME is Biased, But ... April 28, 2011 (Vol. 10, Issue #8) Executive Summary of Complete Issue Physicians Favor Brands With a Compelling Adherence Program Implications of Facebook's Page Commenting Changes A New Estimate of Drug Development Cost FDA to Test New Standard for Easy to Understand Drug Labels Digitally-Feeble Pharma April 15, 2011 (Vol. 10, Issue #7) Executive Summary of Complete Issue The Changing Role of Pharma Sales Reps Mining Mobile Health App User Data Ad Dollars Follow Eyeballs to Web The Phil Mickelson Enbrel Campaign Brits Beat FDA & PhRMA: Issue Social Media Guidance for Pharma March 30, 2011 (Vol. 10, Issue #6) Executive Summary of Complete Issue Adverse Event Reporting: A Missed Opportunity Pharma TeleWeb e-Detailing Are Sales Reps as "Useful" as PhRMA Wants Us to Believe? FDA Issues Long-Awaited Guidance for Mobile Medical Apps March 10, 2011 (Vol. 10, Issue #5) Executive Summary of Complete Issue Pharma Twitter Pioneers Recognized Evidence-Based Pharma Marketing Real Patients Star in Pharma Youtube Videos February 23, 2011 (Vol. 10, Issue #4) Executive Summary of Complete Issue Will Critics Kill Pharma's Social Media Golden Egg Laying Goose? (pdf) HCP Marketing Beyond the Physician: Plugging Into NPs and PAs Google's OneBox Drug "Ads" Steal Clicks Away from Rx Brands AstraZeneca Hosts First-Ever Twitter Chat February 17, 2011 (Vol. 10, Issue #3) Executive Summary of Complete Issue Good Promotion Practices Alliance Breaking the 140-character Limit of Twitter FDA's Abrams Spends 4 Minutes on Social Media! The Socialisation of the Internet is Bogus GSK's U.S. Sales Reps "Europeanized" January 19, 2011 (Vol. 10, Issue #2) Executive Summary of Complete Issue Deal with Lack of Regulations by Developing Best Practices (pdf) Strategies for Marketing Compliance Getting Market Research Right in India & China January 12, 2011 (Vol. 10, Issue #1) Executive Summary of Complete Issue Welcome to the 2010 Pharma Marketing YearBook™ Events I Witnessed, News You Made, & People We Met Pharma Social Media Trials & Tribulations Pharma Spending on Internet, DTC, and Docs Pharma Companies Behaving Badly